Stay updated with breaking news from Binding Affinity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers evaluated the synergistic activity of drugs acting against non-structural protein 1 of SARS-CoV-2 to decrease the viral infectivity.
A recent study published in the iScience Journal assessed the influence of new variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on coronavirus disease 2019 (COVID-19) infectivity and viral neutralization.
A new review paper published in PLoS Pathogens discusses the new variants and the structural mechanism underlying antibody-mediated neutralization as well as mutational antibody escape.
Researchers developed a novel computational model to predict the binding affinity between the hACE2 receptor and the RBD of S protein of SARS-CoV-2.
In a new study, scientists evaluated the cycle threshold values from 1,297 COVID-19-positive saliva samples obtained at a testing lab in the USA.